drugset / Trial / NCT05017987

Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012

NCT05017987 ↗

Phase 1 Completed 36 enrolled Autotelicbio
RandomizedCrossoverOpen-labelTreatment

Summary

To compare and evaluate safety and pharmacokinetic Characteristics after administration of ATB-101 or co-administration of ATB-1011 and ATB-1012 in fasted Healthy Adult Volunteers

Timeline

Start
2021-06-19
Primary completion
2021-07-12
Completion
2021-07-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator ATB-101 Unknown — —
Comparator ATB-1011 Unknown — —
Comparator ATB-1012 Unknown — —

Indications

No indication recorded.